Therapeutics

Tools

Back to the Top
Search By Attributes

Search Results

Name Synonyms FDA Status Company Target Type Therapy Type Approved
For
ALPHA-1062 GLN-1062 ,
Memogain
Alzheimer's Disease (Phase 3) Alpha Cognition, Galantos Pharma Cholinergic System Small Molecule
KarXT xanomeline-trospium Alzheimer's Disease (Phase 3) Karuna Therapeutics Cholinergic System Combination, Small Molecule